Michael Cloonan
Overview
Michael Cloonan received an average of $6M in total compensation, including $429K in salary, at Sage Therapeutics from 2017 to 2020.
Source: SEC filings on April 29, 2021, April 29, 2020, and April 27, 2018.
Related executives
We found seven more executives who work or worked at Sage Therapeutics.
Barry Greene
Sage Therapeutics
Chief Executive Officer
Jeffrey Jonas
Sage Therapeutics
Chief Innovation Officer
Albert Robichaud
Sage Therapeutics
Chief Scientific Officer
Christopher Benecchi
Sage Therapeutics
Chief Commercial Officer
Kimi Iguchi
Sage Therapeutics
Chief Financial Officer
Anne Cook
Sage Therapeutics
General Counsel
Stephen Kanes
Sage Therapeutics